Kiran Amancha,Shivani Chilampalli,Thrimoorthy Potta,Ningxin Yan,Venkat R. Goskonda
申请号：
US15601331
公开号：
US20170252337A1
申请日:
2017.05.22
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The invention provides stable liquid formulations containing naloxone, a pharmaceutically acceptable salt or a derivative thereof. The invention further provides methods for treating opioid dependence, opioid overdose, and congenital insensitivity to pain with anhidrosis by administering the liquid formulations of the present invention intranasally to a patient in need thereof. Further, the invention provides a method of treating opioid dependence, opioid overdose, and congenital insensitivity to pain with anhidrosis by administering intranasally the naloxone formulations of the present invention.
